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ABSTRACT
Background: Most gynaecological causes of death are related to pregnancy such as ectopic pregnancy, unsafe abortion, 
septic incomplete abortion, and gestational trophoblastic diseases. Hence, it was necessary to review the non‑pregnancy 
related causes of gynaecological deaths in our centre.
Aims and Objectives: The aim of this study was to review gynaecological deaths due to non‑pregnancy related causes 
among women in our centre at the University of Calabar Teaching Hospital (UCTH).
Materials and Methods: This was a 5‑year retrospective review of case notes of women who died in the gynaecological 
ward of UCTH. The demographic profile of the women, the diagnosis and the cause of death were extracted for analysis. 
All those whose diagnoses were pregnancy related were excluded.
Results: There were 38 gynaecological deaths, which were not pregnancy related. Of these, ovarian cancer (19) and cervical 
cancer (11) constituted 30 cases or 78.9% of causes of death. Endometrial cancer (3), uterovaginal prolapse (3), uterine 
leiomyosarcoma (1), and vulvovaginal cancer (1) constituted 8 cases or 21.1% of deaths. No deaths were recorded from 
uterine fibroids, dysfunctional uterine bleeding, pelvic inflammatory disease, etc.,
Conclusion: Cancers constitute the majority of causes of gynaecological deaths in women who are not pregnant. This 
emphasises the need for cancer prevention, early diagnosis and effective treatment.
Key words: Death; gynaecological disease; non‑pregnant women; University of Calabar Teaching Hospital.
Introduction
Most of the mortalities in gynaecological wards, especially 
the emergencies, are from complications of early pregnancy. 
Ectopic pregnancy, septic incomplete abortion, unsafe 
abortion and its complications and gestational trophoblastic 
diseases have been reported to contribute to maternal 
deaths.[1,2]
It appears that environmental factors have a significant 
impact on the development of gynaecological cancers, and 
hence emphasis on avoidance of tobacco and unsafe sex, 
adherence to a balanced diet rich in fruits and vegetables, 
moderate exercise and use of the oral contraceptive are 
measures to substantially reduce a woman’s cancer risk.[3] 
Overall, 12.5% of all deaths are attributable to cancer, and if 
the trend continues, it is estimated that by 2020, 16 million 
new cases will be diagnosed per annum, out of which 70% 
will be in developing countries.[4]
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In a comprehensive global cancer statistic from the 
International Agency for Research on Cancer, gynaecological 
cancers constituted approximately 19% of the estimated 5.1 
million new cases, 2.9 million cancer deaths and 13 million 
5‑year prevalent cancer cases among women in the world in 
2002. Cervical cancer accounted for 493000 new cases and 
273000 deaths; uterine body cancer accounted for 199000 
new cases and 50000 deaths; ovarian cancer accounted 
for 204000 new cases and 125000 deaths; cancers of the 
vagina, vulva and choriocarcinoma together constituted 
45900 cases.[5]
Apart from cervical cancer where screening is associated with 
reduction in cancer mortality, screening for vulvar, vaginal, 
endometrial, fallopian tube and ovarian cancers are yet to 
be fully elucidated.[6] Early stage of disease at presentation 
and astute clinical evaluation and management are important 
clinical determinants of good prognosis.
This study was undertaken to review the causes of 
non‑pregnancy related gynaecological deaths among women 
in the gynaecological ward at University of Calabar Teaching 
Hospital (UCTH).
Materials and Methods
This was a 5‑yearretrospective review of case notes of women 
who died in the gynaecological ward from January 1st 2010 
to December 31st 2014. Approval from the Research/Ethics 
Committee was obtained at the proposal stage of this study. 
The demographic profile of the patients, the diagnosis and 
the cause of death were extracted from the case notes for 
analysis. All those whose diagnoses were pregnancy related 
were excluded. In addition, all those whose diagnoses were 
not known were also excluded. In our centre, breast diseases 
are managed by the general surgeons, hence, there were not 
included in our study.
The data was entered and analysed using the Statistical 
Package for Social Sciences (SPSS, IBM) version 22 for patient 
characteristics, causes of death and trend analysis presented 
using frequency tables and line graph.
Results
During the study period, there were 38 non‑pregnancy related 
deaths recorded in the gynaecological ward register. Nineteen 
were due to ovarian cancer, 11 were due to cervical cancer, 
3 were due to endometrial cancer and another 3 were due 
to uterovaginal prolapse, whereas uterine leiomyosarcoma 
and vulvovaginal cancer caused 1 death each. This is shown 
in Table 1.
Cancer (35, 92.1%) was the most common non‑pregnancy 
related gynecological cause of death in this study. The annual 
distribution of the deaths is shown in Table 2. Mean age of 
patients at death was 55.1 ± 24.1 years, ranging from 23 to 
78 years, with the age group distribution shown in Table 3. 
Table 1: Non‑pregnancy related gynaecological cause of death
Cause of death Frequency Percent
Ovarian cancer 19 50.0
Cervical cancer 11 28.9
Endometrial cancer 3 7.9
Uterovaginal prolapsed 3 7.9
Uterine leiomyosarcoma 1 2.6
Vulvovaginal cancer 1 2.6
Total 38 100.0









Table 3: Age distribution of common non‑pregnancy related 
gynecological causes of deaths
Variable (years) Frequency Percent Mean age±SD (range)
General age distribution
20-24 1 2.6 55.1±24.1





20-29 3 15.8 45.7±13.1 





>40 11 100.0 57.0±11.8
Total 11 100.0 (40-78)
Endometrial cancer
>40 3 100.0 55.3±4.5
Total 3 100.0 (51-60)
Uterovaginal prolapse
>40 3 100.0 50.0±10.0





>40 1 100.0 55.0
Total 2 100.0
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Peak year of occurrence of gynecological deaths during the 
study period was 2011, with significant decline in the following 
years. This trend is clearly depicted in Figure 1. Most of the 
deaths were due to ovarian cancer followed by cervical cancer.
Discussion
Gynaecological cancers were the most common non‑pregnancy 
related gynaecological cause of death in our center during 
the study period.
The lead author joined the gynaecological oncology firm 
of this hospital in 2011. Prior to this time, many advanced 
cancer cases were referred or discharged home, but as we 
began dedicated care, many of the patients who probably 
would have died at home were offered palliative care. 
Subsequently, there was a progressive decline in the deaths 
as more surgeries and chemotherapy reduced the death rate 
in our centre. We practice primary cytoreductive surgery 
as well as neoadjuvant chemotherapy, as the case may be, 
in ovarian cancer therapy. Neoadjuvant chemotherapy has 
been successful in our setting, and the results have been 
reported elsewhere.[7] We have also reported the value 
of multidisciplinary collaboration in the management of 
advanced ovarian cancer in our centre.[8]
We do not have a radiotherapy facility in our centre yet. 
Many of the patients with bulky cervical lesions are referred 
for chemoradiation elsewhere, and then asked to come back 
for follow up.
There appears to be an anecdotal increase in the incidence of 
gynaecological cancers in our centre, in south‑south Nigeria. 
This may be in agreement with reports linking infectious 
agents as well as lifestyle and diet westernization along with 
socioeconomic factors to the increase in cancer incidence in 
developing countries.[9]
The mean age at presentation and diagnosis was 
55.1 ± 24.1 years. It was lower for patients with ovarian 
cancer (45.7 ± 13.1 years). It is interesting to note that 26.3% 
of the patients who died of ovarian cancer in our centre were 
less than 40 years old. Painfully, we had a 23‑year‑old never 
pregnant nullipara (Para0+0) who presented with stage IVb 
endodermal sinus tumour. She underwent successful optimal 
debulking surgery though with fertility conservation, and six 
courses of (bleomycin, etoposide, cisplatin) chemotherapy. 
Unfortunately, there was an aggressive relapse, with splenic 
and hepatic infiltrations, and the patient could not afford 
secondary surgery. The role of fertility sparing surgery in 
this case has been found adequate in some studies.[10] In 
a Gynecologic Oncology Group study of 132 survivors of 
platinum‑based chemotherapy for ovarian germ cell tumour, 
median survivor age at diagnosis was 24.3 years and the 
median age at study entry was 35.5 years (approximately 
10 years of follow up), 71 of the 132 (53.8%) of the patients 
had fertility sparing surgery, out of which 24 patients had 
successful pregnancies and deliveries, whereas premature 
menopause was documented in only 2 women.[11]
Ovarian cancer was the most common cause of death in 
our study This was the situation in theUnited States of 
America where malignant neoplasms of the ovary cause 
more deaths than any other female genital cancers.[12] The 
largest number of patients with ovarian cancer are in the 
age group 55–64 years (median 63 years).[13] However, in 
our study, although the mean age for ovarian cancer was 
45.7 ± 13.1 years, the largest number of patients had 
an age range of 50–62 years. This finding is similar to an 
earlier study in Enugu,[14] where the mean age of cases with 
ovarian cancer was 45.4 ± 17.1 years. However, it was 
different from demographic data at a neighboring teaching 
hospital (Abakaliki) where most of the patients with ovarian 
cancer were in the 60–69 age group.[15]
Cervical cancer was the second most common cause of death 
in our study. This is probably because our practice guideline 
has been of early intervention and referral radiotherapy, 
either as adjunctive therapy or primary therapy. Some of 
the patients lost to follow‑up either died in the course of 
radiotherapy or died at home, unable to afford radiotherapy. 
We have reported some of the challenges in the management 
of cervical cancer in our center elsewhere.[16]
The patients who died of endometrial cancer had surgeries 
elsewhere but were referred to our centre. They presented at 
advanced stages and died while been evaluated for treatment. 
The patient with vulvovaginal cancer had also had excisional 


















Figure 1: Trend in non‑pregnancy related gynecological deaths
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with severe anaemia following profuse bleeding from the 
necrotic vaginal cancer lesion and died shortly after blood 
transfusion prior to surgery. The late presentations and 
advanced stages of the disease were responsible for these 
deaths. The patient with leiomyosarcoma died following 
anaesthetic complication, whereas the 3 patients who had 
uterovaginal prolapse (procidentia with decubitus ulcers) 
died of sepsis and complications during surgery.
Conclusion
Gynecological malignancies constitute the majority of 
non‑pregnancy related gynecological causes of death in this 
study. There is the need for an intensified effort toward public 
awareness on prevention, early diagnosis and treatment of 
cancer.
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